Ulcerative colitis

被引:160
作者
Farrell, RJ [1 ]
Peppercorn, MA [1 ]
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Inflammatory Bowel Dis,Div Gastroenterol, Boston, MA 02215 USA
关键词
D O I
10.1016/S0140-6736(02)07499-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ulcerative colitis is a chronic inflammatory disease of the rectum and colon. Results from many studies in people and animals of intestinal inflammation suggest that ulcerative colitis results from environmental factors triggering a loss of tolerance for normal intestinal flora in genetically susceptible individuals. Although progress has been made in the overall management of the disease, no innovative treatment has been developed. By contrast with Crohn's disease, there are few clinical data on biological agents. Probiotics seem the most promising of several experimental and traditional agents that have been investigated in controlled clinical trials.
引用
收藏
页码:331 / 340
页数:10
相关论文
共 159 条
  • [51] Gionchetti P, 1999, DIGEST DIS SCI, V44, P1220
  • [52] Mast cell and neuroendocrine cytoplasmic autoantigen(s) detected by monoclonal pANCA antibodies
    Gordon, LK
    Eggena, M
    Targan, SR
    Braun, J
    [J]. CLINICAL IMMUNOLOGY, 2000, 94 (01) : 42 - 50
  • [53] Gordon LK, 1999, INVEST OPHTH VIS SCI, V40, P1250
  • [54] Nicotine enemas for active ulcerative colitis - a pilot study
    Green, JT
    Thomas, GAO
    Rhodes, J
    Williams, GT
    Evans, BK
    Russell, MAH
    Feyerabend, C
    Rhodes, P
    Sandborn, WJ
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (05) : 859 - 863
  • [55] GREENFIELD SM, 1993, ALIMENT PHARM THERAP, V7, P159
  • [56] A CD4(+) T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
    Groux, H
    OGarra, A
    Bigler, M
    Rouleau, M
    Antonenko, S
    deVries, JE
    Roncarolo, MG
    [J]. NATURE, 1997, 389 (6652) : 737 - 742
  • [57] HALSTENSEN TS, 1995, ADV EXP MED BIOL, V371, P1273
  • [58] HAMILTON MI, 1995, CLIN EXP IMMUNOL, V99, P404
  • [59] Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: A dose-ranging study
    Hanauer, SB
    Robinson, M
    Pruitt, R
    Lazenby, AJ
    Persson, T
    Nilsson, LG
    Walton-Bowen, K
    Haskell, LP
    Levine, JG
    [J]. GASTROENTEROLOGY, 1998, 115 (03) : 525 - 532
  • [60] Evolving treatment strategies for inflammatory bowel disease
    Hanauer, SB
    Dassopoulos, T
    [J]. ANNUAL REVIEW OF MEDICINE, 2001, 52 : 299 - 318